Calcium, vitamin D pills don't prevent fractures, panel says
More than half of American women older than 60 take vitamin D and calcium supplements, but the U.S. Preventive Services Task Force said this week that they're probably wasting their money.
In new recommendations from the federal government's expert panel on preventive medicine, the task force says that most postmenopausal women should not take vitamin D and calcium to reduce their risk of bone fractures. The dosages assessed were 400 international units (IUs) of vitamin D3 and 1,000 milligrams of calcium per day.
The conclusions are based on an analysis of six randomized trials designed to study the health effects of vitamin D and calcium supplements. The largest of these trials was the Women's Health Initiative study, which involved more than 36,000 women from ages 50 to 79. That study found no statistically significant difference in the risk of hip or other fractures among women taking the supplements and those who took placebos.
However, the analysis also made clear that this level of vitamin D and calcium supplementation increases the risk of kidney stones. The added risk is small, but considering the lack of demonstrated benefits, even a small risk can't be justified, the panel said.
The task force also considered whether men and younger women should take the supplements to prevent fractures and determined that there wasn't enough clinical evidence to make a call one way or the other.
“The balance of benefits and harms cannot be determined,” Dr. Virginia A. Moyer wrote on behalf of the task force in a study published online this week by Annals of Internal Medicine.
In a previous analysis, the task force found that senior citizens at increased risk for falls should take about 800 IUs of vitamin D a day. That recommendation hasn't changed.
In an editorial in Annals, nutrition experts Marion Nestle of New York University and Malden Nesheim of Cornell University said the new, unambiguous recommendations should prompt doctors to think twice before advising their healthy postmenopausal patients to take calcium and vitamin D.
— Los Angeles Times
Show commenting policy
TribLive commenting policy
You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.
We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.
While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.
We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers.
We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.
We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.
We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.
We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.